Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Efficacy of sildenafil in male dialysis patients with erectile dysfunction unresponsive to erythropoietin and/or testosterone treatments

International Journal of Impotence Research volume 18, pages 61–68 (2006)Cite this article

Abstract

The aim of this study was to evaluate the effects of recombinant human erythropoietin (Epo), testosterone (T) or a combination of them in the treatment of erectile dysfunction (ED) in hemodialysis patients, as well as the efficacy of sildenafil in patients unresponsive to combination treatment. A total of 23 patients with ED were divided into two groups. The international index of erectile function (IIEF) was used to evaluate ED and treatment response. Patients received Epo or T treatments for 12 weeks. Later on both groups received combination treatment for another 12 weeks. Although IIEF scores increased significantly in both groups after the combination treatment, the score changes were similar. After combination treatment, 16 patients still having IIEF score <26 were given sildenafil treatment in combination with Epo while T was discontinued. Although the IIEF scores increased significantly in all patients (17.4%), only eight of them attained an IIEF score of ≥26. The baseline IIEF scores of the patients with satisfactory response to the sildenafil treatment were higher than those with unsatisfactory response. The patients with a score of ≥22 responded better to the treatment. Although Epo and/or T therapies could partially improve ED in male dialysis patients besides correcting renal anemia and hypogonadism, sildenafil treatment could improve ED in unresponsive patients. Especially, those with higher baseline IIEF scores benefited more.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Palmer BF . Sexual dysfunction in uremia. J Am Soc Nephrol 1999; 10: 1381–1388.

    CAS  PubMed  Google Scholar 

  2. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83–90.

  3. Carney S et al. Erectile dysfunction in end-stage renal disease: suffering in silence. Dial Transplant 2005; 34: 101–104.

    Google Scholar 

  4. Procci WR, Goldstein DA, Adelstein J, Massry SG . Sexual dysfunction in the male patient with uremia: a reappraisal. Kidney Int 1981; 19: 317–323.

    Article  CAS  PubMed  Google Scholar 

  5. Rosas SE et al. Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int 2001; 59: 2259–2266.

    Article  CAS  PubMed  Google Scholar 

  6. Carson CC, Patel MP . The epidemiology, anatomy, physiology, and treatment of erectile dysfunction in chronic renal failure patients. Adv Ren Replace Ther 1999; 6: 296–309.

    Article  CAS  PubMed  Google Scholar 

  7. Turk S et al. Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2001; 16: 1818–1822.

    Article  CAS  PubMed  Google Scholar 

  8. Rosas SE et al. Association of decreased quality of life and erectile dysfunction in hemodialysis patients. Kidney Int 2003; 64: 232–238.

    Article  PubMed  Google Scholar 

  9. Lawrence IG et al. Correcting impotence in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy. Am J Kidney Dis 1998; 31: 313–319.

    Article  CAS  PubMed  Google Scholar 

  10. Ahuja SK, Krane NK, Hellstrom WJ . Penile prostheses in the management of impotence in patients with end-stage renal disease. J La State Med Soc 1998; 150: 32–34.

    CAS  PubMed  Google Scholar 

  11. Lawrence IG et al. Erythropoietin and sexual dysfunction. Nephrol Dial Transplant 1997; 12: 741–747.

    Article  CAS  PubMed  Google Scholar 

  12. Goldstein I et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397–1404.

    Article  CAS  PubMed  Google Scholar 

  13. YenicerioGlu Y et al. Efficacy and safety of sildenafil for treating erectile dysfunction in patients on dialysis. BJU Int 2002; 90: 442–445.

    Article  CAS  PubMed  Google Scholar 

  14. Chen J et al. Clinical efficacy of sildenafil in patients on chronic dialysis. J Urol 2001; 165: 819–821.

    Article  CAS  PubMed  Google Scholar 

  15. Rosas SE, Wasserstein A, Kobrin S, Feldman HI . Preliminary observations of sildenafil treatment for erectile dysfunction in dialysis patients. Am J Kidney Dis 2001; 37: 134–137.

    Article  CAS  PubMed  Google Scholar 

  16. Rosen RC et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.

    Article  CAS  PubMed  Google Scholar 

  17. Procci WR, Martin DJ . Effect of maintenance hemodialysis on male sexual performance. J Nerv Ment Dis 1985; 173: 366–372.

    Article  CAS  PubMed  Google Scholar 

  18. Sobh MA, Abd el Hamid IA, Atta MG, Refaie AF . Effect of erythropoietin on sexual potency in chronic haemodialysis patients. A preliminary study. Scand J Urol Nephrol 1992; 26: 181–185.

    Article  CAS  PubMed  Google Scholar 

  19. Bommer J et al. Improved sexual function during recombinant human erythropoietin therapy. Nephrol Dial Transplant 1990; 5: 204–207.

    Article  CAS  PubMed  Google Scholar 

  20. Schaefer RM et al. Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin. Clin Nephrol 1989; 31: 1–5.

    CAS  PubMed  Google Scholar 

  21. Canadian Erythropoietin study group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving hemodialysis. BMJ 1990; 300: 573–578.

  22. Imagawa A, Kawanishi Y, Numata A . Is erythropoietin effective for impotence in dialysis patients? Nephron 1990; 54: 95–96.

    Article  CAS  PubMed  Google Scholar 

  23. Gomez F, de la Cueva R, Wauters JP, Lemarchand-Beraud T . Endocrine abnormalities in patients undergoing long-term hemodialysis: the role of prolactin. Am J Med 1980; 68: 522–530.

    Article  CAS  PubMed  Google Scholar 

  24. Steffensen G, Aunsholt NA . Does erythropoietin cause hormonal changes in haemodialysis patients? Nephrol Dial Transplant 1993; 8: 1215–1218.

    CAS  PubMed  Google Scholar 

  25. Bernini GP et al. Effects of erythropoietin administration on prolactin secretion in normal subjects. Nephron 1993; 65: 522–526.

    Article  CAS  PubMed  Google Scholar 

  26. Haley NR, Matsumoto AM, Eschbach JW, Adamson JW . Low testosterone-(T) levels increase in male hemodialysis-patients (HDP) treated with recombinant human erythropoietin (rHuEPO) [Abstract]. Kidney Int 1989; 35: 193.

    Google Scholar 

  27. Foresta C et al. Erythropoietin stimulates testosterone production in man. J Clin Endocrinol Metab 1994; 78: 753–756.

    CAS  PubMed  Google Scholar 

  28. Punzo G et al. Use of sildenafil in the chronic uremic patient. Minerva Urol Nefrol 2001; 53: 39–43.

    CAS  PubMed  Google Scholar 

  29. Barton CH, Mirahmandi MK, Vaziri ND . Effects of long term testosteron administration on pituitary-testicular axis in and stage renal failure. Nephron 1982; 31: 61–64.

    Article  CAS  PubMed  Google Scholar 

  30. Paul HR, McLeish D, Rao TKS, Friedman EA . Initial experience with sildenafil for erectile dysfunction in maintenance hemodialysis (MD) patients [Abstract]. J Am Soc Nephrol 1999; 11: 222A.

    Google Scholar 

  31. Sahin Y et al. Efficacy and safety of sildenafil citrate in hemodialysis patients. Transplant Proc 2004; 36: 56–58.

    Article  CAS  PubMed  Google Scholar 

  32. Seibel I, Poli De Figueiredo CE, Teloken C, Moraes JF . Efficacy of oral sildenafil in hemodialysis patients with erectile dysfunction. J Am Soc Nephrol 2002; 13: 2770–2775.

    Article  CAS  PubMed  Google Scholar 

  33. Chatterjee R et al. A novel therapy with testosterone and sildenafil for erectile dysfunction in patients on renal dialysis or after renal transplantation. J Fam Plann Reprod Health Care 2004; 30: 88–90.

    Article  PubMed  Google Scholar 

  34. Mohamed EA, MacDowall P, Coward RA . Timing of sildenafil therapy in dialysis patients-lessons following an episode of hypotension. Nephrol Dial Transplant 2000; 15: 926–927.

    Article  CAS  PubMed  Google Scholar 

  35. Grossmann EB et al. The pharmacokinetics and hemodynamics of sildenafil citrate in male hemodialysis patients. Kidney Int 2004; 66: 367–374.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Levent Celik, MD for assistance of papaverine test.

Author information

Authors and Affiliations

  1. Department of Nephrology, Uludağ University Medical School, Bursa, Turkey

    A Tas, A Ersoy, M Gullulu & M Yurtkuran

  2. Department of Endocrinology and Metabolism, Uludağ University Medical School, Bursa, Turkey

    C Ersoy

Authors
  1. A Tas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Ersoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C Ersoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Gullulu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Yurtkuran
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Ersoy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tas, A., Ersoy, A., Ersoy, C. et al. Efficacy of sildenafil in male dialysis patients with erectile dysfunction unresponsive to erythropoietin and/or testosterone treatments. Int J Impot Res 18, 61–68 (2006). https://doi.org/10.1038/sj.ijir.3901372

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901372

Keywords

This article is cited by

Search

Advanced search

Quick links